Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis-Reference-Cited by-同舟云学术

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

Published:2018-07 Issue:1 Volume:69 Page:18-24
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Petta Salvatore,Adinolfi Luigi Elio,Fracanzani Anna Ludovica,Rini Francesca,Caldarella Rosalia,Calvaruso Vincenza,Cammà Calogero,Ciaccio Marcello,Di Marco Vito,Grimaudo Stefania,Licata Anna,Marrone Aldo,Nevola Riccardo,Pipitone Rosaria Maria,Pinto Antonio,Rinaldi Luca,Torres Daniele,Tuttolomondo Antonino,Valenti Luca,Fargion Silvia,Craxì Antonio

Publisher

Elsevier BV

Subject

Hepatology

Reference50 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

2. Extrahepatic morbidity and mortality of chronic hepatitis C;Negro;Gastroenterology,2015

3. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden;Younossi;Gastroenterology,2016

4. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C;Targher;J Hepatol,2007

5. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis;Adinolfi;Atherosclerosis,2012

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus infection associated with coronary and thoracic aortic atherosclerosis;The American Journal of the Medical Sciences;2024-09

2. Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database;Psychiatry Research;2024-09

3. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

4. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals;Pathogens;2024-04-19

5. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication;Pathogens;2024-03-25